AngioDynamics Inc (ANGO) - Total Liabilities
Based on the latest financial reports, AngioDynamics Inc (ANGO) has total liabilities worth $96.34 Million USD as of May 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ANGO asset resilience ratio to evaluate the company's liquid asset resilience ratio.
AngioDynamics Inc - Total Liabilities Trend (2002–2026)
This chart illustrates how AngioDynamics Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is AngioDynamics Inc's balance sheet.
AngioDynamics Inc Competitors by Total Liabilities
The table below lists competitors of AngioDynamics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
eXp World Holdings, Inc.
NASDAQ:AGNT
|
USA | $258.32 Million |
|
JBG SMITH Properties
NYSE:JBGS
|
USA | $2.70 Billion |
|
General Interface Solution GIS Holding Ltd
TW:6456
|
Taiwan | NT$31.79 Billion |
|
New Trend International Logis-Tech Co Ltd
SHE:300532
|
China | CN¥3.74 Billion |
|
Turaco Gold Ltd
AU:TCG
|
Australia | AU$2.89 Million |
|
M Grass Ecology and Environment Group Co Ltd
SHE:300355
|
China | CN¥10.08 Billion |
|
Rashtriya Chemicals and Fertilizers Limited
NSE:RCF
|
India | Rs115.80 Billion |
|
ZheJiang RIFA Digital Precision Machinery Co Ltd
SHE:002520
|
China | CN¥1.54 Billion |
Liability Composition Analysis (2002–2026)
This chart breaks down AngioDynamics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of AngioDynamics Inc to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AngioDynamics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AngioDynamics Inc (2002–2026)
The table below shows the annual total liabilities of AngioDynamics Inc from 2002 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-05-31 | $96.34 Million | -0.86% |
| 2025-05-31 | $97.17 Million | -13.30% |
| 2024-05-31 | $112.08 Million | -27.38% |
| 2023-05-31 | $154.34 Million | +20.33% |
| 2022-05-31 | $128.26 Million | +5.15% |
| 2021-05-31 | $121.98 Million | -12.65% |
| 2020-05-31 | $139.64 Million | -36.99% |
| 2019-05-31 | $221.62 Million | +36.07% |
| 2018-05-31 | $162.88 Million | -14.69% |
| 2017-05-31 | $190.93 Million | -13.62% |
| 2016-05-31 | $221.04 Million | -3.31% |
| 2015-05-31 | $228.60 Million | -12.84% |
| 2014-05-31 | $262.26 Million | -1.05% |
| 2013-05-31 | $265.05 Million | +31.42% |
| 2012-05-31 | $201.69 Million | +534.27% |
| 2011-05-31 | $31.80 Million | -2.39% |
| 2010-05-31 | $32.58 Million | -10.77% |
| 2009-05-31 | $36.51 Million | -31.16% |
| 2008-05-31 | $53.03 Million | +12.07% |
| 2007-05-31 | $47.32 Million | +248.94% |
| 2006-05-31 | $13.56 Million | +28.40% |
| 2005-05-31 | $10.56 Million | -15.46% |
| 2004-05-31 | $12.49 Million | -51.13% |
| 2003-05-31 | $25.57 Million | +22.09% |
| 2002-05-31 | $20.94 Million | -- |
About AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vesse… Read more